Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Elimination of vancomycin during hemofiltration.

P Rawer1, K E Seim

  • 1Medizinische Klinik, I, Stadtkrankenhaus Wetzlar, FRG.

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|June 1, 1989
PubMed
Summary

This study provides guidelines for vancomycin dosing in patients with acute renal failure undergoing hemofiltration. Measuring initial vancomycin levels accurately predicts elimination, enabling safe and effective treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Cyclosporin A in the therapy of nephrotic syndrome].

Immunitat und Infektion·1990
Same author

Seroconversion rate, hepatitis B vaccination, hemodialysis, and zinc supplementation.

Kidney international. Supplement·1987
Same author

Early detection of amatoxins in human mushroom poisoning.

Archives of toxicology·1986
Same author

Plasma aldosterone, cortisol and electrolyte concentrations in physical exercise after magnesium supplementation.

Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie·1984
Same author

Efficacy of membrane filtration, influence on hemostasis, immunoglobulins and inflammation mediators during daily plasma exchanges.

The International journal of artificial organs·1983
Same author

Ultrashort hemodiafiltration: efficiency and hemodynamic tolerance.

Clinical nephrology·1983

Area of Science:

  • Nephrology
  • Pharmacology
  • Critical Care Medicine

Background:

  • Vancomycin is crucial for treating infections but requires dose adjustment in renal impairment.
  • Acute renal failure (ARF) and hemofiltration complicate vancomycin pharmacokinetics.
  • Establishing clear guidelines for vancomycin therapy during hemofiltration is essential.

Purpose of the Study:

  • To develop guidelines for vancomycin treatment in patients with ARF undergoing hemofiltration.
  • To determine the relationship between plasma vancomycin levels and elimination during hemofiltration.
  • To enable accurate vancomycin dosage adjustments based on hemofiltration parameters.

Main Methods:

  • Studied 27 hemofiltration treatments in four anuric patients.
  • Measured plasma vancomycin levels and elimination rates.

Related Experiment Videos

  • Utilized regression analysis to correlate initial vancomycin concentration with elimination.

    • Main Results:

    • A strong linear relationship (r = 0.91) was found between initial vancomycin concentration and total vancomycin eliminated.
    • Initial plasma concentration can predict total vancomycin elimination during hemofiltration.
    • Hemofiltration effectively removes vancomycin, suggesting its utility in treating vancomycin intoxication.

    Conclusions:

    • Vancomycin dosage can be determined by monitoring initial plasma concentrations in patients undergoing hemofiltration.
    • Hemofiltration is an effective modality for managing vancomycin intoxication.
    • These findings support evidence-based guidelines for vancomycin therapy in critically ill patients with renal failure.